Figshare最新文献

筛选
英文 中文
Rhamnolipid/Fullerene Nanocomposites as Potent RadicalScavengers for Acute Severe Ulcerative Colitis Prevention: A Low-DoseTherapeutic Approach 鼠李糖脂/富勒烯纳米复合材料作为预防急性严重溃疡性结肠炎的有效自由基清除剂:一种低剂量治疗方法
Figshare Pub Date : 2025-11-26 DOI: 10.1021/acsomega.5c08545.s001
Yuxuan Xia (14800378), Xinyao Teng (22685187), Xinyue Hu (5436146), Jia Tang (196660), Bingxue Yu (4513264), Jie Wan (3183759), Yonghua Zhou (151227), Liu Hong (1875280), Cheng Yang (273624)
{"title":"Rhamnolipid/Fullerene Nanocomposites as Potent RadicalScavengers for Acute Severe Ulcerative Colitis Prevention: A Low-DoseTherapeutic Approach","authors":"Yuxuan Xia (14800378), Xinyao Teng (22685187), Xinyue Hu (5436146), Jia Tang (196660), Bingxue Yu (4513264), Jie Wan (3183759), Yonghua Zhou (151227), Liu Hong (1875280), Cheng Yang (273624)","doi":"10.1021/acsomega.5c08545.s001","DOIUrl":"https://doi.org/10.1021/acsomega.5c08545.s001","url":null,"abstract":"As a common recurrent disease of ulcerative colitis (UC), acute severe ulcerative colitis (ASUC) causes long-term pain and heavy economic losses to patients. Although fullerene (C<sub>60</sub>) is considered an excellent antioxidant, its therapeutic application in UC is often hindered by absorption challenges due to intestinal mucosal damage. Here, we report the superior effect of rhamnolipid hybrid C<sub>60</sub> (RL/C<sub>60</sub>) nanocomposites on preventing ASUC. Benefiting from their high hydrophilicity and uniform particle size, RL/C<sub>60</sub> shows a remarkable free-radical-scavenging ability in vitro, biological safety, and intracellular anti-inflammatory ability, which was better than those of the common medication 5-aminosalicylic acid (5-ASA). In vivo experimental results further demonstrated that prophylactic oral administration of low-dose (0.4 mg/kg) RL/C<sub>60</sub> successfully alleviated ASUC symptoms in mice to a level close to health by repairing intestinal mucosa and reducing inflammatory cytokine levels. Our findings highlight RL/C<sub>60</sub> as a promising nanotherapeutic strategy for preventing ASUC, offering a safer and more effective alternative to conventional treatments.","PeriodicalId":522237,"journal":{"name":"Figshare","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147893912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书